Triphenylphosphonium-Conjugated Palmitic Acid for Mitochondrial Targeting of Pancreatic Cancer Cells: Proteomic and Molecular Evidence.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
20 Jun 2024
Historique:
received: 15 05 2024
revised: 12 06 2024
accepted: 17 06 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Pancreatic ductal adenocarcinoma (PDAC)'s resistance to therapies is mainly attributed to pancreatic cancer stem cells (PCSCs). Mitochondria-impairing agents can be used to hamper PCSC propagation and reduce PDAC progression. Therefore, to develop an efficient vector for delivering drugs to the mitochondria, we synthesized tris(3,5-dimethylphenyl)phosphonium-conjugated palmitic acid. Triphenylphosphonium (TPP) is a lipophilic cationic moiety that promotes the accumulation of conjugated agents in the mitochondrion. Palmitic acid (PA), the most common saturated fatty acid, has pro-apoptotic activity in different types of cancer cells. TPP-PA was prepared by the reaction of 16-bromopalmitic acid with TPP, and its structure was characterized by

Identifiants

pubmed: 38928494
pii: ijms25126790
doi: 10.3390/ijms25126790
pii:
doi:

Substances chimiques

Palmitic Acid 2V16EO95H1
Organophosphorus Compounds 0
Reactive Oxygen Species 0
Proteome 0
Antineoplastic Agents 0
triphenylphosphonium 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Giuliana Siragusa (G)

Department of Biotechnology, University of Verona, Strada le Grazie 15, 37134 Verona, Italy.

Jessica Brandi (J)

Department of Biotechnology, University of Verona, Strada le Grazie 15, 37134 Verona, Italy.

Tristan Rawling (T)

School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.

Michael Murray (M)

Molecular Drug Development Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

Daniela Cecconi (D)

Department of Biotechnology, University of Verona, Strada le Grazie 15, 37134 Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH